How would I detect aggregation in a GLP-1 receptor agonist vial without sending it to PeptideMeter?

Stated plainly: aggregation · a GLP-1 receptor agonist · PeptideMeter.

Everything I have found on this is either a forum aside or a product page, neither of which I trust.

I am comfortable with the arithmetic; what I am missing is the procedural detail around it.

What is the correct sequence, and where is the step that people usually skip?

Start with the seal, the stopper and the label, in that order, and then look at the contents against a light and a dark background.

Inspect the powder against both a white and a black background under good light. Discolouration, browning or a yellow tinge on a peptide that should be white is worth photographing before doing anything else.

Weigh the vial if you have a scale reading to a milligram. It will not give you content, but a vial several tens of milligrams lighter than its siblings is a fill problem.

Container closure integrity depends on the crimp and stopper seating, which is why those are the first things checked in any incoming-goods inspection.

Nothing here is medical advice, and research-use compounds are not approved for human use.

Photograph anything unexpected before touching it further.

edited 1 Apr 2026 by ahmed_zerouali — added the citation requested in comments

The honest answer is that most defects found are cosmetic and the few that are not are obvious once you know the list.

Confirm the lot code is physically on the vial and legible, and that it matches the certificate and the invoice. A code on the box only ties a certificate to a box.

Check the fill looks proportionate to the label claim. Ten milligrams of peptide is a small volume of powder, but it is not nothing, and a vial that looks empty is worth a photograph.

Melt-back and collapse are documented lyophilisation cycle defects with well-described visual appearances.

The lot code has to be on the vial. A code on the box ties nothing to anything.

The relevant principle is that anything you find before reconstitution is the supplier's, and anything you find after might be yours.

Check the aluminium crimp is fully seated with no lift at the edge, the flip-off cap has not been previously removed, and the stopper sits flush without a visible gap or dimple.

Worth being precise here: after reconstitution, hold against a light and look for haze, floaters or a Tyndall effect. A clear solution that goes clear on contact is what a well-made preparation looks like.

Lot traceability to the primary container rather than to secondary packaging is a basic requirement of any documentation system worth the name.

Passing inspection is a weak result. It rules out the obvious and nothing else.

The underlying point is that photograph anything unexpected before you touch it further; a photograph is the only evidence that survives.

Melt-back at the stopper — a glassy ring where the cake meets the closure — indicates the cycle ran warm at the top of the vial. Cosmetic in most cases, informative always.

Visual inspection for particulate matter is a pharmacopoeial requirement for parenteral products and the standard technique uses both light and dark backgrounds.

The caveat is that inspection cannot detect identity, purity, content or endotoxin, which are the things most likely to be wrong.

Inspect before reconstitution. Afterwards you cannot tell whose particle it is.

The relevant detail is that this is a two-minute procedure that resolves a large fraction of the questions people ask afterwards.

Look for fibres, glass fragments and dark particulate in the cake. Glass is the one that matters and is usually a crimping or handling artefact rather than a synthesis one.

Do not open a vial you intend to return or claim on; photograph it sealed first.

Crimp, stopper, label, contents. Light background and dark background.